Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nucleosides | 13 | 2023 | 30 | 4.330 |
Why?
|
| Purine Nucleosides | 9 | 2016 | 14 | 2.840 |
Why?
|
| Inosine | 8 | 2012 | 16 | 2.460 |
Why?
|
| Amides | 4 | 2022 | 71 | 1.950 |
Why?
|
| Pyrimidine Nucleosides | 3 | 2022 | 9 | 1.870 |
Why?
|
| Palladium | 12 | 2013 | 30 | 1.790 |
Why?
|
| Organophosphorus Compounds | 8 | 2017 | 37 | 1.670 |
Why?
|
| Triazoles | 6 | 2012 | 102 | 1.630 |
Why?
|
| Catalysis | 18 | 2022 | 187 | 1.430 |
Why?
|
| Deoxyguanosine | 6 | 2015 | 36 | 1.340 |
Why?
|
| Carbon | 5 | 2017 | 128 | 1.250 |
Why?
|
| Adenosine | 2 | 2021 | 62 | 1.210 |
Why?
|
| Ethers | 3 | 2022 | 21 | 1.170 |
Why?
|
| Antineoplastic Agents | 5 | 2022 | 1019 | 1.100 |
Why?
|
| Phenanthrenes | 3 | 2015 | 16 | 0.990 |
Why?
|
| Cladribine | 2 | 2015 | 3 | 0.950 |
Why?
|
| Antiviral Agents | 3 | 2024 | 195 | 0.940 |
Why?
|
| Boron Compounds | 2 | 2016 | 18 | 0.850 |
Why?
|
| Guanosine | 2 | 2015 | 28 | 0.840 |
Why?
|
| Cytidine | 1 | 2024 | 5 | 0.840 |
Why?
|
| Prodrugs | 1 | 2024 | 31 | 0.820 |
Why?
|
| Amines | 4 | 2021 | 41 | 0.800 |
Why?
|
| Nucleic Acids | 1 | 2023 | 25 | 0.770 |
Why?
|
| Oxygen | 3 | 2016 | 218 | 0.760 |
Why?
|
| Molecular Structure | 11 | 2016 | 570 | 0.750 |
Why?
|
| Aza Compounds | 1 | 2022 | 11 | 0.730 |
Why?
|
| Heterocyclic Compounds | 1 | 2022 | 23 | 0.720 |
Why?
|
| Boronic Acids | 2 | 2015 | 21 | 0.650 |
Why?
|
| Purines | 3 | 2011 | 40 | 0.640 |
Why?
|
| Structure-Activity Relationship | 6 | 2017 | 506 | 0.610 |
Why?
|
| Magnetic Resonance Spectroscopy | 10 | 2009 | 301 | 0.600 |
Why?
|
| Fluorides | 1 | 2019 | 19 | 0.590 |
Why?
|
| Phosphates | 1 | 2019 | 54 | 0.590 |
Why?
|
| Deoxyadenosines | 2 | 2017 | 8 | 0.590 |
Why?
|
| DNA Adducts | 5 | 2007 | 37 | 0.580 |
Why?
|
| Phosphines | 2 | 2009 | 6 | 0.570 |
Why?
|
| Epoxy Compounds | 4 | 2007 | 15 | 0.540 |
Why?
|
| Butanones | 1 | 2016 | 5 | 0.500 |
Why?
|
| Benzaldehydes | 1 | 2015 | 8 | 0.470 |
Why?
|
| Arylsulfonates | 2 | 2005 | 2 | 0.470 |
Why?
|
| Naphthalenes | 1 | 2015 | 38 | 0.460 |
Why?
|
| Models, Molecular | 5 | 2013 | 876 | 0.460 |
Why?
|
| Carcinogens | 3 | 2007 | 126 | 0.440 |
Why?
|
| Azides | 2 | 2012 | 10 | 0.420 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2015 | 247 | 0.420 |
Why?
|
| Alkynes | 2 | 2012 | 52 | 0.410 |
Why?
|
| Nitrogen | 2 | 2017 | 84 | 0.410 |
Why?
|
| Crystallography, X-Ray | 5 | 2015 | 280 | 0.400 |
Why?
|
| Acetic Acid | 1 | 2013 | 19 | 0.400 |
Why?
|
| Oxidation-Reduction | 4 | 2016 | 457 | 0.380 |
Why?
|
| RNA Viruses | 1 | 2012 | 22 | 0.380 |
Why?
|
| DNA Viruses | 1 | 2012 | 14 | 0.370 |
Why?
|
| Ruthenium | 1 | 2011 | 16 | 0.350 |
Why?
|
| Molecular Conformation | 5 | 2017 | 155 | 0.330 |
Why?
|
| Oxides | 1 | 2011 | 100 | 0.330 |
Why?
|
| Tetrazoles | 1 | 2010 | 46 | 0.310 |
Why?
|
| Pyrimidines | 1 | 2010 | 139 | 0.300 |
Why?
|
| Biphenyl Compounds | 1 | 2009 | 53 | 0.300 |
Why?
|
| Oximes | 1 | 2009 | 7 | 0.300 |
Why?
|
| Monosaccharides | 1 | 2009 | 13 | 0.300 |
Why?
|
| Guanine | 1 | 2009 | 44 | 0.300 |
Why?
|
| Nitriles | 1 | 2009 | 81 | 0.290 |
Why?
|
| Cell Line, Tumor | 4 | 2022 | 2676 | 0.290 |
Why?
|
| Thymidine | 1 | 2007 | 15 | 0.270 |
Why?
|
| Benzopyrenes | 1 | 2007 | 3 | 0.260 |
Why?
|
| Xanthenes | 1 | 2006 | 11 | 0.250 |
Why?
|
| Polymers | 1 | 2008 | 155 | 0.250 |
Why?
|
| Pyrenes | 2 | 2003 | 26 | 0.250 |
Why?
|
| Stereoisomerism | 5 | 2012 | 169 | 0.250 |
Why?
|
| DNA | 2 | 2007 | 592 | 0.240 |
Why?
|
| Benzo(a)pyrene | 2 | 2003 | 128 | 0.230 |
Why?
|
| Cell Proliferation | 3 | 2017 | 1455 | 0.220 |
Why?
|
| Temperature | 1 | 2005 | 313 | 0.210 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2017 | 157 | 0.210 |
Why?
|
| Hydroxylamines | 1 | 2024 | 4 | 0.210 |
Why?
|
| Hydrocarbons, Fluorinated | 3 | 2017 | 17 | 0.210 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2017 | 245 | 0.210 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2019 | 140 | 0.200 |
Why?
|
| Nucleotides | 1 | 2023 | 37 | 0.190 |
Why?
|
| Quinazolinones | 1 | 2022 | 10 | 0.190 |
Why?
|
| Oxidants | 1 | 2022 | 42 | 0.190 |
Why?
|
| Hydroxyl Radical | 1 | 2021 | 14 | 0.180 |
Why?
|
| Isomerism | 2 | 2015 | 64 | 0.180 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 1124 | 0.180 |
Why?
|
| Organometallic Compounds | 2 | 2013 | 71 | 0.170 |
Why?
|
| Humans | 8 | 2024 | 43102 | 0.170 |
Why?
|
| Copper | 2 | 2012 | 134 | 0.160 |
Why?
|
| Water | 1 | 2021 | 316 | 0.150 |
Why?
|
| Indicators and Reagents | 3 | 2011 | 61 | 0.150 |
Why?
|
| Chromatography, Thin Layer | 1 | 2019 | 39 | 0.150 |
Why?
|
| Peptides | 1 | 2022 | 372 | 0.150 |
Why?
|
| Chromatography, Gel | 1 | 2019 | 51 | 0.150 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2019 | 104 | 0.150 |
Why?
|
| Propanols | 1 | 2017 | 6 | 0.130 |
Why?
|
| HIV-2 | 1 | 2017 | 9 | 0.130 |
Why?
|
| Luminescent Measurements | 1 | 2017 | 26 | 0.130 |
Why?
|
| Free Radicals | 1 | 2017 | 70 | 0.130 |
Why?
|
| Benzimidazoles | 1 | 2017 | 43 | 0.130 |
Why?
|
| Animals | 4 | 2022 | 16992 | 0.120 |
Why?
|
| Herpesvirus 1, Human | 1 | 2017 | 64 | 0.120 |
Why?
|
| Dogs | 1 | 2017 | 204 | 0.120 |
Why?
|
| Ligands | 2 | 2009 | 388 | 0.120 |
Why?
|
| Leukemia, Hairy Cell | 1 | 2015 | 3 | 0.120 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2015 | 11 | 0.120 |
Why?
|
| Halogenation | 1 | 2015 | 19 | 0.120 |
Why?
|
| Lymphoma, T-Cell | 1 | 2015 | 29 | 0.120 |
Why?
|
| Solvents | 2 | 2006 | 113 | 0.120 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2015 | 99 | 0.120 |
Why?
|
| Amination | 2 | 2004 | 6 | 0.110 |
Why?
|
| Mice | 2 | 2017 | 6644 | 0.100 |
Why?
|
| Cell Line | 1 | 2017 | 1410 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 2 | 2012 | 508 | 0.100 |
Why?
|
| Cyclization | 1 | 2012 | 50 | 0.090 |
Why?
|
| Carbonates | 1 | 2012 | 4 | 0.090 |
Why?
|
| Cesium | 1 | 2012 | 8 | 0.090 |
Why?
|
| Dioxanes | 1 | 2012 | 11 | 0.090 |
Why?
|
| Cell Survival | 1 | 2015 | 945 | 0.090 |
Why?
|
| Coordination Complexes | 1 | 2012 | 28 | 0.090 |
Why?
|
| Hela Cells | 1 | 2012 | 376 | 0.090 |
Why?
|
| HIV-1 | 1 | 2017 | 755 | 0.080 |
Why?
|
| Solutions | 1 | 2010 | 65 | 0.080 |
Why?
|
| Electrons | 1 | 2009 | 76 | 0.070 |
Why?
|
| Deoxyribonucleosides | 1 | 2008 | 2 | 0.070 |
Why?
|
| Benzene Derivatives | 1 | 2007 | 3 | 0.070 |
Why?
|
| Sulfonic Acids | 1 | 2007 | 7 | 0.070 |
Why?
|
| Bromine | 1 | 2007 | 2 | 0.070 |
Why?
|
| Acetals | 1 | 2007 | 2 | 0.070 |
Why?
|
| Bromine Compounds | 1 | 2007 | 1 | 0.070 |
Why?
|
| Benzene | 1 | 2007 | 17 | 0.070 |
Why?
|
| Photochemistry | 1 | 2007 | 57 | 0.070 |
Why?
|
| Chemistry, Organic | 1 | 2007 | 6 | 0.070 |
Why?
|
| DNA, Neoplasm | 1 | 2007 | 92 | 0.070 |
Why?
|
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 1 | 2007 | 7 | 0.060 |
Why?
|
| Mathematical Computing | 1 | 2007 | 9 | 0.060 |
Why?
|
| Hydrogen | 1 | 2007 | 47 | 0.060 |
Why?
|
| Ions | 1 | 2007 | 71 | 0.060 |
Why?
|
| Nitrates | 1 | 2007 | 63 | 0.060 |
Why?
|
| Toluene | 1 | 2006 | 11 | 0.060 |
Why?
|
| Mass Spectrometry | 1 | 2007 | 280 | 0.060 |
Why?
|
| Chlorine | 1 | 2003 | 10 | 0.050 |
Why?
|
| Polysaccharides | 1 | 2003 | 72 | 0.050 |
Why?
|
| Bay-Region, Polycyclic Aromatic Hydrocarbon | 1 | 2003 | 3 | 0.010 |
Why?
|
| Hydrocarbons, Brominated | 1 | 2003 | 4 | 0.010 |
Why?
|
| Intercalating Agents | 1 | 2003 | 13 | 0.010 |
Why?
|
| Methanol | 1 | 2003 | 22 | 0.010 |
Why?
|
| Cations | 1 | 2003 | 50 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2003 | 84 | 0.010 |
Why?
|
| Cattle | 1 | 2003 | 498 | 0.010 |
Why?
|